Alpha DNA Investment Management’s Halliburton HAL Stock Holding History

Alpha DNA Investment Management’s Portfolio HAL Stock Details HAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-34,819	Closed	-$1.15M	–	193
2023 Q2	$1.15M	Buy	+34,819	New	+$1.1M	0.38%	45
2022 Q4	–	Sell	-31,658	Closed	-$779K	–	173
2022 Q3	$779K	Sell	31,658 -6,565	-17%	-$188K	0.65%	45
2022 Q2	$1.2M	Buy	+38,223	New	+$1.42M	1.02%	13
2021 Q2	–	Sell	-2,645	Closed	-$56K	–	328
2021 Q1	$56K	Buy	2,645 +1,245	+89%	+$26.1K	0.06%	157
2020 Q4	$26K	Buy	+1,400	New	+$21.7K	0.03%	236

Other funds holding HAL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Alpha DNA Investment Management's HAL Position: Q3 2023 in Review

Alpha DNA Investment Management sold out of Halliburton (HAL) in Q3 2023, closing a stake of 34,819 shares — an estimated $1.15M sold.

Alpha DNA Investment Management first reported a position in HAL in Q4 2020 and held it in 5 quarters. The position peaked at $1.2M in Q2 2022. 957 funds tracked by Wall St. Rank hold HAL as of Q3 2023.

Alpha DNA Investment Management reported no remaining Halliburton position as of Q3 2023 after selling out during the quarter.
Alpha DNA Investment Management sold 34,819 Halliburton shares in Q3 2023, an estimated $1.15M.
Alpha DNA Investment Management first reported a position in Halliburton in Q4 2020 and held it in 5 quarters.
Alpha DNA Investment Management's Halliburton position peaked at $1.2M in Q2 2022.
957 funds tracked by Wall St. Rank held Halliburton as of Q3 2023.

Based on Alpha DNA Investment Management's 13F filing for Q3 2023, filed 7 Nov 2023.